No Data
No Data
Cartesian Therapeutics Announces New Employment Inducement Grants
Express News | Needham Reiterates Buy on Cartesian Therapeutics, Maintains $42 Price Target
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family reasons, effecti
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
Cartesian Therapeutics, Inc. (RNAC) announced positive top-line results from its mid-stage study evaluating lead candidate Descartes-08 in patients with generalized myasthenia gravis (MG), an autoimmune disease associated with muscle weakness.
Cartesian Therapeutics Price Target Cut to $49.00/Share From $54.00 by HC Wainwright & Co.
Cartesian Therapeutics Price Target Cut to $49.00/Share From $54.00 by HC Wainwright & Co.
Syncona Board Member Takes Role at Cartesian Therapeutics
andy(三叔) : $Chicken Soup for the Soul Entertainment (CSSE.US)$ $Chicken Soup For The Soul Entmt Inc 9.50% Notes Due 2025 Usd25 (CSSEN.US)$ $Chicken Soup for the Soul Entertainment Inc (CSSEP.US)$
TrytosaveabitOP andy(三叔): It’s a bankruptcy play from Redbox filing for protection!